As per Intent Market Research, the Methionine Market was valued at USD 6.0 billion in 2024-e and will surpass USD 9.1 billion by 2030; growing at a CAGR of 7.1% during 2024 - 2030.
Zacks Investment Research on MSN1d
Bayer Licenses PRMT5 inhibitor From Suzhou Puhe BioPharmaBayer BAYRY announced a licensing agreement with Suzhou Puhe BioPharma Co., a clinical-stage biotechnology company.Suzhou Puhe BioPharma is focused on the research and development of innovative ...
The Vietnam Methionine Market was valued at USD 31.37 million in 2023 and is expected to experience steady growth, with a CAGR of 4.24% projected through 2029. Methionine, an essential amino acid, ...
The global methionine market is on a trajectory of significant expansion, with projections indicating a rise from USD 4,066.2 million in 2021 to approximately USD 5,728.1 million by 2028. This growth, ...
Just like the mechanical components in cars or computers, the molecules inside a cell can sometimes malfunction. When this happens during DNA replication, the result is an unpredictable change in ...
Evonik is continuing to optimise its global production setup for MetAMINO® (DL-methionine) with a technical upgrade of its ...
Evonik is investing a low double-digit million euro sum to upgrade its European methionine Verbund in Antwerp and Wesseling, part of its global n ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback